Hansa Biopharma AB's (HNSBF) CEO Søren Tulstrup on Q1 2022 Results - Earnings Call Transcript
Hansa Biopharma AB (publ) (OTC:HNSBF) Q1 2022 Earnings Conference Call April 21, 2022 8:00 AM ET Company Participants Søren Tulstrup – Chief Executive Officer Conference Call Participants...
Source: seekingalpha.com